Nkarta

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Nkarta and other ETFs, options, and stocks.

About NKTX

Nkarta, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer. The firm’s product include NKX101, which is in Phase I clinical trials for the treatment of relapsed/refractory acute myeloid leukemia or higher risk myelodysplastic syndromes, and NKX019, a pre-clinical product, which is based on the ability to treat various B cell malignancies by targeting the CD19 antigen found on these types of cancerous cells.

CEO

Paul J. Hastings

CEOPaul J. Hastings

Employees

150

Employees150

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2005

Founded2005

Employees

150

Employees150

NKTX Key Statistics

Market cap

504.20M

Market cap504.20M

Price-Earnings ratio

-2.99

Price-Earnings ratio-2.99

Dividend yield

—

Dividend yield—

Average volume

889.96K

Average volume889.96K

High today

$7.56

High today$7.56

Low today

$7.02

Low today$7.02

Open price

$7.50

Open price$7.50

Volume

673.04K

Volume673.04K

52 Week high

$16.24

52 Week high$16.24

52 Week low

$1.28

52 Week low$1.28

Analyst ratings

100%

of 10 ratings

Buy

100%

Hold

Sell